ker-050
keros therapeutics
['ker-050', 'keros']
keros therapeutics presents clinical trial and preclinical study results from its ker-050 program and preclinical data from its alk2 inhibitor program at the 28th annual congress of the european hematology association 
We provide a complete array of research services as required for Investigational New Drug Applications (IND).